Physician

Rohit R Lakhanpal, M.D.

According to 2025 Medicare claims, Rohit Lakhanpal, M.D. (NPI: 1104870401) practices ophthalmology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Carroll, MD. This provider's primary affiliated billing organization is THE RETINA GROUP OF WASHINGTON, PLLC (NPI: 1225001654; TIN: 521570295) and primary practice location at 21157-3051. Lakhanpal is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Lakhanpal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,413 traditional Medicare patients, billed 46,399 HCPCS/CPT codes, and received $7,576,402 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 75 prescription claims across 32 beneficiaries totaling $5,160 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 53 records totaling $30,596. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,304,350 to $7,576,402. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $41,795 to $5,160. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.